A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE study

This publication has 22 references indexed in Scilit:

• Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta‐analysis of eradication of Helicobacter pylori
  Alimentary Pharmacology & Therapeutics, 2000
• High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong
  Alimentary Pharmacology & Therapeutics, 2000
• Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States
  International Journal of Antimicrobial Agents, 1999
• A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication rates
  Alimentary Pharmacology & Therapeutics, 1999
• The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis
  American Journal of Gastroenterology, 1999
• The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta‐analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole
  Alimentary Pharmacology & Therapeutics, 1999
• Prevalence and demographic determinants of metronidazole resistance by Helicobacter pylori in a large cosmopolitan cohort of Australian dyspeptic patients
  Australian and New Zealand Journal of Medicine, 1998
• Introduction
  Gastroenterology, 1997
• Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.
  Gut, 1997
• V. Helicobacter pylori therapy: Effect on peptic ulcer disease
  Journal of Gastroenterology and Hepatology, 1991